Frontiers in Aging Neuroscience

Article	Citations
Microglia Polarization From M1 to M2 in Neurodegenerative Diseases	307
Mitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease	287
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2019	201
Machine Learning for the Diagnosis of Parkinson's Disease: A Review of Literature	190
Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD Study	171
The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases	158
Cellular Senescence in Brain Aging	151
Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer’s Disease: A Focus on Aducanumab and Lecanemab	139
The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis	135
The Impact of Disease Comorbidities in Alzheimer's Disease	132
Cholesterol and Alzheimer’s Disease; From Risk Genes to Pathological Effects	127
Alzheimer’s Disease: An Update and Insights Into Pathophysiology	103
Inflammation From Peripheral Organs to the Brain: How Does Systemic Inflammation Cause Neuroinflammation?	96
Functional Aging in Male C57BL/6J Mice Across the Life-Span: A Systematic Behavioral Analysis of Motor, Emotional, and Memory Function to Define an Aging Phenotype	95
The Impact of COVID-19 Quarantine on Patients With Dementia and Family Caregivers: A Nation-Wide Survey	82
Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease	82
The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain	81
Microglia and Neuroinflammation: Crucial Pathological Mechanisms in Traumatic Brain Injury-Induced Neurodegeneration	81
The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review	79
Mitophagy in Cerebral Ischemia and Ischemia/Reperfusion Injury	72
Exploring Sex-Related Differences in Microglia May Be a Game-Changer in Precision Medicine	71
Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough	70
Mild Behavioral Impairment Is Associated With Atrophy of Entorhinal Cortex and Hippocampus in a Memory Clinic Cohort	70
Normal Aging Induces Changes in the Brain and Neurodegeneration Progress: Review of the Structural, Biochemical, Metabolic, Cellular, and Molecular Changes	68
Grip Strength and the Risk of Cognitive Decline and Dementia: A Systematic Review and Meta-Analysis of Longitudinal Cohort Studies	68

Impact of COVID-19 on Mitochondrial-Based Immunity in Aging and Age-Related Diseases	67
COVCOG 2: Cognitive and Memory Deficits in Long COVID: A Second Publication From the COVID and Cognition Study	66
Hearing Loss and Cognition: What We Know and Where We Need to Go	64
Prevalence of Alzheimer's Disease and Parkinson's Disease in China: An Updated Systematical Analysis	62
Update on the Mechanism and Treatment of Sevoflurane-Induced Postoperative Cognitive Dysfunction	61
Diffusion Tensor Imaging Along the Perivascular Space Index in Different Stages of Parkinson’s Disease	59
Effects of Virtual Reality Intervention on Cognition and Motor Function in Older Adults With Mild Cognitive Impairment or Dementia: A Systematic Review and Meta-Analysis	58
The Cross-Links of Endoplasmic Reticulum Stress, Autophagy, and Neurodegeneration in Parkinson’s Disease	56
Heterogeneity in Regional Damage Detected by Neuroimaging and Neuropathological Studies in Older Adults With COVID-19: A Cognitive-Neuroscience Systematic Review to Inform the Long-Term Impact of the	56
Past, Present, and Future of Non-invasive Brain Stimulation Approaches to Treat Cognitive Impairment in Neurodegenerative Diseases: Time for a Comprehensive Critical Review	55
Role of the Extracellular Matrix in Alzheimer’s Disease	55
Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target	54
Iron Dyshomeostasis and Ferroptosis: A New Alzheimer’s Disease Hypothesis?	53
Overview of Meta-Analyses of Five Non-pharmacological Interventions for Alzheimer's Disease	52
Endogenous and Exogenous Estrogen Exposures: How Women’s Reproductive Health Can Drive Brain Aging and Inform Alzheimer’s Prevention	51
Comparing Pre-trained and Feature-Based Models for Prediction of Alzheimer's Disease Based on Speech	51
Characterization of Age-Related Differences in the Human Choroid Plexus Volume, Microstructural Integrity, and Blood Perfusion Using Multiparameter Magnetic Resonance Imaging	50
Multiple Roles in Neuroprotection for the Exercise Derived Myokine Irisin	49
Enteric Nervous System: The Bridge Between the Gut Microbiota and Neurological Disorders	48
The Unifying Hypothesis of Alzheimer’s Disease: Heparan Sulfate Proteoglycans/Glycosaminoglycans Are Key as First Hypothesized Over 30 Years Ago	48
Cholesterol Hydroxylating Cytochrome P450 46A1: From Mechanisms of Action to Clinical Applications	48
Deep Brain Stimulation for Alzheimer's Disease: Stimulation Parameters and Potential Mechanisms of Action	47
Decreased Retinal Vascular Density in Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI): An Optical Coherence Tomography Angiography (OCTA) Study	47
PET Neuroimaging of Alzheimer's Disease: Radiotracers and Their Utility in Clinical Research	46
A Meta-Analysis of Brain DNA Methylation Across Sex, Age, and Alzheimer's Disease Points for Accelerated Epigenetic Aging in Neurodegeneration	46
The Glymphatic System: A Novel Therapeutic Target for Stroke Treatment	45
Acoustic and Language Based Deep Learning Approaches for Alzheimer's Dementia Detection From Spontaneous Speech	45
The Role of Protein Persulfidation in Brain Aging and Neurodegeneration	45
Glymphatic Dysfunction in Patients With Ischemic Stroke	45
Brain Ischemia as a Prelude to Alzheimer's Disease	44
Neuregulins in Neurodegenerative Diseases	44
RETRACTED: ADVIAN: Alzheimer's Disease VGG-Inspired Attention Network Based on Convolutional Block Attention Module and Multiple Way Data Augmentation	44
Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery Platform	43
The Eminent Role of microRNAs in the Pathogenesis of Alzheimer's Disease	43
Brain Entropy Mapping in Healthy Aging and Alzheimer’s Disease	43
Mitochondrial Dysfunction in Parkinson’s Disease: From Mechanistic Insights to Therapy	43
Mechanisms of Ferroptosis and Emerging Links to the Pathology of Neurodegenerative Diseases	43
Identification and immunological characterization of cuproptosis-related molecular clusters in Alzheimer's disease	43
Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis	42
Local Brain-Age: A U-Net Model	41
The Role of Microglia in Perioperative Neuroinflammation and Neurocognitive Disorders	41
APP, PSEN1, and PSEN2 Variants in Alzheimer’s Disease: Systematic Re-evaluation According to ACMG Guidelines	41
Prevalence and Associated Risk Factors of Cognitive Frailty: A Systematic Review and Meta-Analysis	41
Novel STMN2 Variant Linked to Amyotrophic Lateral Sclerosis Risk and Clinical Phenotype	40
The Association Between Glymphatic System Dysfunction and Cognitive Impairment in Cerebral Small Vessel Disease	40
Dysfunction of the Glymphatic System Might Be Related to Iron Deposition in the Normal Aging Brain	40
Plasma and CSF Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: A Cross-Sectional and Longitudinal Study	40
A Large-Scale Open Motion Dataset (KFall) and Benchmark Algorithms for Detecting Pre-impact Fall of the Elderly Using Wearable Inertial Sensors	40
Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders	39
The Emerging Role of the Interplay Among Astrocytes, Microglia, and Neurons in the Hippocampus in Health and Disease	39

Effectiveness of an Innovative Cognitive Treatment and Telerehabilitation on Subjects With Mild Cognitive Impairment: A Multicenter, Randomized, Active-Controlled Study	39
Neuropsychological impairment in post-COVID condition individuals with and without cognitive complaints	39
From Neurodevelopmental to Neurodegenerative Disorders: The Vascular Continuum	38
Being the Family Caregiver of a Patient With Dementia During the Coronavirus Disease 2019 Lockdown	38
Cognitive Reserve in Model Systems for Mechanistic Discovery: The Importance of Longitudinal Studies	38
Functional Metabolic Mapping Reveals Highly Active Branched-Chain Amino Acid Metabolism in Human Astrocytes, Which Is Impaired in iPSC-Derived Astrocytes in Alzheimer's Disease	38
Cholesterol, Atherosclerosis, and APOE in Vascular Contributions to Cognitive Impairment and Dementia (VCID): Potential Mechanisms and Therapy	38
Dual-Task Exercise to Improve Cognition and Functional Capacity of Healthy Older Adults	38
Mitochondrial Dynamics: A Potential Therapeutic Target for Ischemic Stroke	38
Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEε4 and Trem2*R47H	37
Characterization of EEG Data Revealing Relationships With Cognitive and Motor Symptoms in Parkinson's Disease: A Systematic Review	37
Mitochondrial Behavior in Axon Degeneration and Regeneration	37
Propionate and Alzheimer’s Disease	37
Vascular Dementia and Underlying Sex Differences	37
Resilience and Psychobiological Response to Stress in Older People: The Mediating Role of Coping Strategies	36
Functional MRI-Specific Alterations in Salience Network in Mild Cognitive Impairment: An ALE Meta-Analysis	36
Predicting MCI to AD Conversation Using Integrated sMRI and rs-fMRI: Machine Learning and Graph Theory Approach	36
Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials	36
Multi-Targets: An Unconventional Drug Development Strategy for Alzheimer’s Disease	36
Current and future therapeutic strategies for Alzheimer’s disease: an overview of drug development bottlenecks	36
Prevalence and Predictors of Prolonged Cognitive and Psychological Symptoms Following COVID-19 in the United States	36
Cerebral small vessel disease: Pathological mechanisms and potential therapeutic targets	36
Western Diet Induces Impairment of Liver-Brain Axis Accelerating Neuroinflammation and Amyloid Pathology in Alzheimer's Disease	36
Carbonic Anhydrases as Potential Targets Against Neurovascular Unit Dysfunction in Alzheimer’s Disease and Stroke	35
Intranasal Transplantation of Human Neural Stem Cells Ameliorates Alzheimer's Disease-Like Pathology in a Mouse Model	35
Age-Related Alterations in DTI Metrics in the Human Brain—Consequences for Age Correction	35
Probiotic Supplementation Facilitates Recovery of 6-OHDA-Induced Motor Deficit via Improving Mitochondrial Function and Energy Metabolism	35
Association of inflammation and cognition in the elderly: A systematic review and meta-analysis	35
Phosphatidylserine, inflammation, and central nervous system diseases	35
Insights Into the Role of CSF1R in the Central Nervous System and Neurological Disorders	34
Role of mTOR-Regulated Autophagy in Synaptic Plasticity Related Proteins Downregulation and the Reference Memory Deficits Induced by Anesthesia/Surgery in Aged Mice	34
Epigenetics in depression and gut-brain axis: A molecular crosstalk	34
Administration of Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI Improves Cognitive and Memory Function in the Mouse Model of Alzheimer’s Disease	34
Wearable Devices for Assessing Function in Alzheimer's Disease: A European Public Involvement Activity About the Features and Preferences of Patients and Caregivers	34
The role of brain derived neurotrophic factor in central nervous system	33
Hearing Loss and Dementia: A Meta-Analysis of Prospective Cohort Studies	33
Deep Convolutional Neural Networks With Ensemble Learning and Generative Adversarial Networks for Alzheimer’s Disease Image Data Classification	33
Contributions of Hippocampal Volume to Cognition in Healthy Older Adults	33
Impact of COVID-19 Pandemic on Patients With Neurodegenerative Diseases	33
Epigenetics in Alzheimer’s Disease	33
Identification of Circular RNA hsa_Circ_0003391 in Peripheral Blood Is Potentially Associated With Alzheimer's Disease	33
Application of Evans Index in Normal Pressure Hydrocephalus Patients: A Mini Review	33
Posterior Cingulate Cortex Network Predicts Alzheimer's Disease Progression	32
Intracranial Atherosclerotic Plaque Characteristics and Burden Associated With Recurrent Acute Stroke: A 3D Quantitative Vessel Wall MRI Study	32
Gut-Derived Metabolite Phenylacetylglutamine and White Matter Hyperintensities in Patients With Acute Ischemic Stroke	32
Prediction Models for Conversion From Mild Cognitive Impairment to Alzheimer’s Disease: A Systematic Review and Meta-Analysis	32
Delirium: A Marker of Vulnerability in Older People	32
MicroRNAs as Potential Orchestrators of Alzheimer's Disease-Related Pathologies: Insights on Current Status and Future Possibilities	32
Microvascular Changes in Parkinson’s Disease- Focus on the Neurovascular Unit	32
The Future of GDNF in Parkinson's Disease	32
Homocysteine and Folic Acid: Risk Factors for Alzheimer's Disease—An Updated Meta-Analysis	32
The Emerging Role of Neuropeptides in Parkinson’s Disease	32
Mitochondrial CHCHD2: Disease-Associated Mutations, Physiological Functions, and Current Animal Models	32
Role of Neuron and Glia in Alzheimer’s Disease and Associated Vascular Dysfunction	32
A Comprehensive Phenotype of Non-motor Impairments and Distribution of Alpha-Synuclein Deposition in Parkinsonism-Induced Mice by a Combination Injection of MPTP and Probenecid	32
The Influence of Demographics and Vascular Risk Factors on Glymphatic Function Measured by Diffusion Along Perivascular Space	31
Aged Microglia in Neurodegenerative Diseases: Microglia Lifespan and Culture Methods	31
Alzheimer’s Disease Diagnosis and Biomarker Analysis Using Resting-State Functional MRI Functional Brain Network With Multi-Measures Features and Hippocampal Subfield and Amygdala Volume of Structural	31
Efficacy and Safety of Probiotics for the Treatment of Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease: A Systematic Review and Meta-Analysis	31
Factors Associated With the Dilation of Perivascular Space in Healthy Elderly Subjects	31
The Complexity of Microglial Interactions With Innate and Adaptive Immune Cells in Alzheimer’s Disease	31
The Role of Microglia in Alzheimer’s Disease From the Perspective of Immune Inflammation and Iron Metabolism	31
The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases	31
The Roles of Optogenetics and Technology in Neurobiology: A Review	31
Potential Therapies for Cerebral Edema After Ischemic Stroke: A Mini Review	31
Neuroinflammation: A Possible Link Between Chronic Vascular Disorders and Neurodegenerative Diseases	31
Deep Learning Model for Prediction of Progressive Mild Cognitive Impairment to Alzheimer’s Disease Using Structural MRI	31
Neuroprotective Roles of the Reverse Transsulfuration Pathway in Alzheimer’s Disease	31
Medial Temporal Lobe Subregional Atrophy in Aging and Alzheimer's Disease: A Longitudinal Study	31
COVCOG 1: Factors Predicting Physical, Neurological and Cognitive Symptoms in Long COVID in a Community Sample. A First Publication From the COVID and Cognition Study	30
Mitochondria: Novel Mechanisms and Therapeutic Targets for Secondary Brain Injury After Intracerebral Hemorrhage	30
Exogenous Alpha-Synuclein Evoked Parkin Downregulation Promotes Mitochondrial Dysfunction in Neuronal Cells. Implications for Parkinson’s Disease Pathology	30
Altered Cholesterol Homeostasis in Huntington’s Disease	30
Transneuronal Degeneration in the Brain During Glaucoma	30
Regulation of Mitophagy by Sirtuin Family Proteins: A Vital Role in Aging and Age-Related Diseases	30
Are social isolation and loneliness associated with cognitive decline in ageing?	30
Transcranial Direct Current Stimulation for Parkinson's Disease: A Systematic Review and Meta-Analysis	30
Neurovascular Alterations in Vascular Dementia: Emphasis on Risk Factors	30
Stress Granules and Neurodegenerative Disorders: A Scoping Review	30
Active Life for Brain Health: A Narrative Review of the Mechanism Underlying the Protective Effects of Physical Activity on the Brain	29

A Comprehensive Overview of the Complex Role of Oxidative Stress in Aging, The Contributing Environmental Stressors and Emerging Antioxidant Therapeutic Interventions	29
Conversion of Reactive Astrocytes to Induced Neurons Enhances Neuronal Repair and Functional Recovery After Ischemic Stroke	29
Gray Matter Deterioration Pattern During Alzheimer's Disease Progression: A Regions-of-Interest Based Surface Morphometry Study	29
Impaired Learning and Memory Ability Induced by a Bilaterally Hippocampal Injection of Streptozotocin in Mice: Involved With the Adaptive Changes of Synaptic Plasticity	29
Ketogenic diet prevents chronic sleep deprivation-induced Alzheimer’s disease by inhibiting iron dyshomeostasis and promoting repair via Sirt1/Nrf2 pathway	29
Exercise-Induced Benefits for Alzheimer’s Disease by Stimulating Mitophagy and Improving Mitochondrial Function	29
Aberrant Amplitude of Low-Frequency Fluctuations in Different Frequency Bands in Patients With Parkinson’s Disease	29
Sex Differences in Brain and Cognition in de novo Parkinson's Disease	28
The Role of Non-coding RNAs in Alzheimer’s Disease: From Regulated Mechanism to Therapeutic Targets and Diagnostic Biomarkers	28
Age-Associated Neurological Complications of COVID-19: A Systematic Review and Meta-Analysis	28
Cognitive Assessment in SARS-CoV-2 Patients: A Systematic Review	28
Language Impairment in Alzheimer’s Disease—Robust and Explainable Evidence for AD-Related Deterioration of Spontaneous Speech Through Multilingual Machine Learning	28
A Signature of Five Long Non-Coding RNAs for Predicting the Prognosis of Alzheimer's Disease Based on Competing Endogenous RNA Networks	28
Widespread Decreases in Cerebral Copper Are Common to Parkinson's Disease Dementia and Alzheimer's Disease Dementia	28
Acupuncture for the Treatment of Alzheimer's Disease: An Overview of Systematic Reviews	28
Sex-Specific Cross Tissue Meta-Analysis Identifies Immune Dysregulation in Women With Alzheimer’s Disease	27
Sex and gender considerations in Alzheimer’s disease: The Women’s Brain Project contribution	27
Cortical Engagement Metrics During Reactive Balance Are Associated With Distinct Aspects of Balance Behavior in Older Adults	27
Convergent Functional Changes of Default Mode Network in Mild Cognitive Impairment Using Activation Likelihood Estimation	27
Brain NAD Is Associated With ATP Energy Production and Membrane Phospholipid Turnover in Humans	27
Resveratrol Modulates the Gut-Brain Axis: Focus on Glucagon-Like Peptide-1, 5-HT, and Gut Microbiota	27
A Shift in Tissue Stiffness During Hippocampal Maturation Correlates to the Pattern of Neurogenesis and Composition of the Extracellular Matrix	27
Threshold effects of the relationship between physical exercise and cognitive function in the short-sleep elder population	27
Exploring the Pharmacological Potential of Metformin for Neurodegenerative Diseases	27
The Periodontal Pathogen Fusobacterium nucleatum Exacerbates Alzheimer’s Pathogenesis via Specific Pathways	27
The Potential of Ferroptosis-Targeting Therapies for Alzheimer’s Disease: From Mechanism to Transcriptomic Analysis	27
Redox signaling and metabolism in Alzheimer's disease	27
Effects of Virtual Reality-Based Intervention on Cognition, Motor Function, Mood, and Activities of Daily Living in Patients With Chronic Stroke: A Systematic Review and Meta-Analysis of Randomized Co	27
Early Noise-Induced Hearing Loss Accelerates Presbycusis Altering Aging Processes in the Cochlea	27
Circulating Inflamma-miRs as Potential Biomarkers of Cognitive Impairment in Patients Affected by Alzheimer’s Disease	26
LncRNA-T199678 Mitigates α-Synuclein-Induced Dopaminergic Neuron Injury via miR-101-3p	26
The Neutrophil to Lymphocyte Ratio Is Associated With the Risk of Subsequent Dementia in the Framingham Heart Study	26
Genome-Wide Association Study of Alzheimer’s Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomark	26
Secular Trends in the Incidence of and Mortality Due to Alzheimer’s Disease and Other Forms of Dementia in China From 1990 to 2019: An Age-Period-Cohort Study and Joinpoint Analysis	26
Characteristics of Neural Network Changes in Normal Aging and Early Dementia	26
A Neuron, Microglia, and Astrocyte Triple Co-culture Model to Study Alzheimer’s Disease	26
Relieving Cellular Energy Stress in Aging, Neurodegenerative, and Metabolic Diseases, SIRT1 as a Therapeutic and Promising Node	26
Melatonin as an Anti-Aging Therapy for Age-Related Cardiovascular and Neurodegenerative Diseases	26
Exploring the Key Genes and Identification of Potential Diagnosis Biomarkers in Alzheimer’s Disease Using Bioinformatics Analysis	26
Growth Differentiation Factor 15 Regulates Oxidative Stress-Dependent Ferroptosis Post Spinal Cord Injury by Stabilizing the p62-Keap1-Nrf2 Signaling Pathway	26
Sleep in Older Adults and Its Possible Relations With COVID-19	26
Artificial Intelligence Can Effectively Predict Early Hematoma Expansion of Intracerebral Hemorrhage Analyzing Noncontrast Computed Tomography Image	26
Risk Factors Affecting Cognitive Impairment of the Elderly Aged 65 and Over: A Cross-Sectional Study	26
Inflammation Mediated Epileptogenesis as Possible Mechanism Underlying Ischemic Post-stroke Epilepsy	26
Role of BDNF/ProBDNF Imbalance in Postoperative Cognitive Dysfunction by Modulating Synaptic Plasticity in Aged Mice	26
Acupuncture-Related Therapies for Parkinson's Disease: A Meta-Analysis and Qualitative Review	26
Association of Peripheral Blood Cell Profile With Alzheimer's Disease: A Meta-Analysis	26
The Relationship of Malnutrition With Cognitive Function in the Older Chinese Population: Evidence From the Chinese Longitudinal Healthy Longevity Survey Study	25
The Unfolded Protein Response in Immune Cells as an Emerging Regulator of Neuroinflammation	25
Niacin Enhancement for Parkinson’s Disease: An Effectiveness Trial	25
Enriched Environment Attenuates Pyroptosis to Improve Functional Recovery After Cerebral Ischemia/Reperfusion Injury	25
Challenges and Limitations of Targeting the Keap1-Nrf2 Pathway for Neurotherapeutics: Bach1 De-Repression to the Rescue	25
Gray Matter Atrophy in Amnestic Mild Cognitive Impairment: A Voxel-Based Meta-Analysis	25
Awareness of Cognitive Decline in Patients With Alzheimer's Disease: A Systematic Review and Meta-Analysis	25
Ovarian steroid hormones: A long overlooked but critical contributor to brain aging and Alzheimer’s disease	25
Enhanced Interplay of Neuronal Coherence and Coupling in the Dying Human Brain	25
Potential Mechanism Underlying Exercise Upregulated Circulating Blood Exosome miR-215-5p to Prevent Necroptosis of Neuronal Cells and a Model for Early Diagnosis of Alzheimer’s Disease	25
The Occurrence of Alzheimer’s Disease and Parkinson’s Disease in Individuals With Osteoporosis: A Longitudinal Follow-Up Study Using a National Health Screening Database in Korea	25
Serum Uric Acid and the Risk of Dementia: A Systematic Review and Meta-Analysis	25
Exercise for Osteoarthritis: A Literature Review of Pathology and Mechanism	25
Individual Differences in Interoceptive Accuracy Are Correlated With Salience Network Connectivity in Older Adults	25
Validity Evidence for the Research Category, “Cognitively Unimpaired – Declining,” as a Risk Marker for Mild Cognitive Impairment and Alzheimer’s Disease	25
Predicting Dementia With Prefrontal Electroencephalography and Event-Related Potential	25
Machine Learning for Detecting Parkinson’s Disease by Resting-State Functional Magnetic Resonance Imaging: A Multicenter Radiomics Analysis	24
Safety and Feasibility of Tele-Supervised Home-Based Transcranial Direct Current Stimulation for Major Depressive Disorder	24
Admission Random Blood Glucose, Fasting Blood Glucose, Stress Hyperglycemia Ratio, and Functional Outcomes in Patients With Acute Ischemic Stroke Treated With Intravenous Thrombolysis	24
Evidence for Peripheral Immune Activation in Parkinson’s Disease	24
Assessment of the Concordance and Diagnostic Accuracy Between Elecsys and Lumipulse Fully Automated Platforms and Innotest	24
Liraglutide Reduces Vascular Damage, Neuronal Loss, and Cognitive Impairment in a Mixed Murine Model of Alzheimer’s Disease and Type 2 Diabetes	24
Cadmium, an Environmental Contaminant, Exacerbates Alzheimer’s Pathology in the Aged Mice’s Brain	24
Revisiting Stem Cell-Based Clinical Trials for Ischemic Stroke	24
Monthly At-Home Computerized Cognitive Testing to Detect Diminished Practice Effects in Preclinical Alzheimer's Disease	24
Effects of Exergaming-Based Tai Chi on Cognitive Function and Dual-Task Gait Performance in Older Adults With Mild Cognitive Impairment: A Randomized Control Trial	24
AChRs Degeneration at NMJ in Aging-Associated Sarcopenia–A Systematic Review	24
Serum miR-214 Serves as a Biomarker for Prodromal Parkinson’s Disease	24
Age-Related Hearing Loss: Sensory and Neural Etiology and Their Interdependence	24
Neurofeedback and the Aging Brain: A Systematic Review of Training Protocols for Dementia and Mild Cognitive Impairment	24
Interplay Between Microglia and Alzheimer’s Disease—Focus on the Most Relevant Risks: APOE Genotype, Sex and Age	24
Systemic-Immune-Inflammation Index as a Promising Biomarker for Predicting Perioperative Ischemic Stroke in Older Patients Who Underwent Non-cardiac Surgery	24
Genetic architecture of Parkinson’s disease subtypes – Review of the literature	24
Repetitive Transcranial Magnetic Stimulation for Improving Cognitive Function in Patients With Mild Cognitive Impairment: A Systematic Review	24
Leisure Activities, APOE ε4, and Cognitive Decline: A Longitudinal Cohort Study	24
The Influence of Aging, Hearing, and Tinnitus on the Morphology of Cortical Gray Matter, Amygdala, and Hippocampus	24
DNA Damage, Defective DNA Repair, and Neurodegeneration in Amyotrophic Lateral Sclerosis	23
Exercise Modifies the Transcriptional Regulatory Features of Monocytes in Alzheimer’s Patients: A Multi-Omics Integration Analysis Based on Single Cell Technology	23
Experiences of Stroke Survivors and Clinicians With a Fully Immersive Virtual Reality Treadmill Exergame for Stroke Rehabilitation: A Qualitative Pilot Study	23
Manganese Exposure Aggravates β-Amyloid Pathology by Microglial Activation	23
PINK1/Parkin Pathway Activation for Mitochondrial Quality Control – Which Is the Best Molecular Target for Therapy?	23
Peripheral Inflammation and Cognitive Performance in Middle-Aged Adults With and Without Type 2 Diabetes: Results From the ENBIND Study	23
Extracellular Vesicles From 3xTg-AD Mouse and Alzheimer’s Disease Patient Astrocytes Impair Neuroglial and Vascular Components	23
Different Perivascular Space Burdens in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson’s Disease	23
Functional and Phenotypic Diversity of Microglia: Implication for Microglia-Based Therapies for Alzheimer’s Disease	23
Melatonin Treatment for Sleep Disorders in Parkinson's Disease: A Meta-Analysis and Systematic Review	23
The role of neutrophils in the dysfunction of central nervous system barriers	23
Distinctive Oculomotor Behaviors in Alzheimer's Disease and Frontotemporal Dementia	23